Turning Point in the Treatment of Mantle Cell Lymphoma-Reference-Cited by-同舟云学术

Turning Point in the Treatment of Mantle Cell Lymphoma

Published:2019 Issue:1 Volume:62 Page:001-007
ISSN:1346-8049
Container-title:Yonago Acta Medica
language:en
Short-container-title:Yonago Acta Med.

Author:

Motokura Toru¹

Affiliation:

1. Division of Clinical Laboratory Medicine, Department of Pathophysiological and Therapeutic Science, School of Medicine, Tottori University Faculty of Medicine, Yonago 683-8503, Japan

Publisher

Tottori University Faculty of Medicine

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/yam/62/1/62_2019.03.001/_pdf

Reference49 articles.

1. 1 A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. Blood. 1997;89:3909-18. PMID: 9166827

2. 2 Chihara D, Ito H, Matsuda T, Shibata A, Katsumi A, Nakamura S, et al.Differences in incidence and trends of haematological malignancies in Japan and the United States. Br J Haematol. 2014;164:536-45. doi:10.1111/bjh.12659 PMID: 24245986 PMCID: PMC3907701

3. 3 Raffeld M, Jaffe ES.bcl-1, t(11;14), and mantle cell-derived lymphomas. Blood. 1991;78:259-63. PMID: 2070063

4. 4 Motokura T, Bloom T, Kim HG, Juppner H, Ruderman JV, Kronenberg HM, et al.A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature. 1991;350:512-5. doi:10.1038/350512a0 PMID: 1826542

5. 5 Banks PM, Chan J, Cleary ML, Delsol G, De Wolf-Peeters C, Gatter K, et al.Mantle cell lymphoma, a proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol. 1992;16:637-40. PMID: 1530105

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BAFF receptor antibody for mantle cell lymphoma therapy;OncoImmunology;2021-01-01